These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Off-label use of stents: bare-metal versus drug-eluting stents. Girod JP; Mulukutla SR; Marroquin OC Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1095-106. PubMed ID: 18793112 [TBL] [Abstract][Full Text] [Related]
30. Recommendations regarding stent selection in relation to the timing of noncardiac surgery postpercutaneous coronary intervention. Satler LF Catheter Cardiovasc Interv; 2004 Oct; 63(2):146-7. PubMed ID: 15390238 [No Abstract] [Full Text] [Related]
31. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Williams DO; Abbott JD; Kip KE; Circulation; 2006 Nov; 114(20):2154-62. PubMed ID: 17060386 [TBL] [Abstract][Full Text] [Related]
32. [State of treatment of coronary artery disease by drug releasing stents]. Müller R; Büllesfeld L; Gerckens U; Grube E Herz; 2002 Sep; 27(6):508-13. PubMed ID: 12378395 [TBL] [Abstract][Full Text] [Related]
33. Rationale for low-molecular weight heparin in coronary stenting. Zidar JP Am Heart J; 1997 Nov; 134(5 Pt 2):S81-7. PubMed ID: 9396639 [TBL] [Abstract][Full Text] [Related]
34. Coronary stent coatings. van Beusekom HM; Serruys PW; van der Giessen WJ Coron Artery Dis; 1994 Jul; 5(7):590-6. PubMed ID: 7952420 [No Abstract] [Full Text] [Related]
35. Pediatric cardiology--Part I. Rao PS Indian J Pediatr; 1991; 58(4):439-40. PubMed ID: 1800327 [No Abstract] [Full Text] [Related]
36. [Cardiology. New problems to solve, new therapies to validate]. Bélanger LG; Doucet P; Karam J; Lavallée JP; Larin P; Lenis J; Ouellet CA; Charbonneau M; Phaneuf G; Timothée JR Union Med Can; 1986 Jul; 115(7):432-3. PubMed ID: 3750565 [No Abstract] [Full Text] [Related]
37. [Legal requirements for the coating of coronary stents with medications by cardiologists outside clinical investigations. Information of the Federal Institute for Medications and Medical Products and the central position of the various regions for health preservation in using medications and medical products (ZLG)]. von Mallek D; Tolle I; Stephan K; Edelhäuser R; Heinz B Clin Res Cardiol; 2006 Jul; 95(7):388-91. PubMed ID: 16724171 [No Abstract] [Full Text] [Related]
39. Cardiology and emergency medicine: united we stand, divided we fall. Gibler WB; Topol EJ; Holroyd B; Armstrong PW Ann Emerg Med; 2002 Feb; 39(2):164-7. PubMed ID: 11823771 [No Abstract] [Full Text] [Related]
40. Management of acute coronary syndromes based on risk stratification by biochemical markers: an idea whose time has come. Roberts R; Fromm RE Circulation; 1998 Nov; 98(18):1831-3. PubMed ID: 9799199 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]